PHD2/HDACs-IN-1 is a potent PHD2 / HDACs hybrid inhibitor ( IC 50 s of 1.15 μM, 19.75 μM, 26.60 μM and 15.98 μM for PHD2, HDAC1 , HDAC2 and HDAC6 , respectively). PHD2/HDACs-IN-1 is a low-toxicity renoprotective agent for research of cisplatin-induced acute kidney injury (AKI).